You are here

exenatide

AstraZeneca Posts Positive Data on its Type II Diabetes Drug

Yahoo/Zacks.com

Wed, 09/24/14 - 08:00 am

Investors pump $200M into Intarcia's PhIII for once-yearly diabetes therapy

First Word Pharma

Tue, 04/1/14 - 03:34 pm

Blockbuster Breakup: Amylin Buys Out Lilly's Exenatide Rights

Motley Fool

Tue, 11/8/11 - 10:31 am

Exenatide tQT Study Showed No Prolongation of QT Interval

Pipeline Review

Sun, 07/10/11 - 11:30 am

Amylin Braces for Big Event of 2010, the (Hoped-For) Approval of Once-Weekly Diabetes Drug

Xconomy

Mon, 01/25/10 - 12:33 pm

Amylin Gets Positive Results

Yahoo/Zacks.com

Tue, 07/21/09 - 09:17 am

Lilly, Amylin sign exenatide deal

Bizjournals.com

Thu, 04/30/09 - 07:26 am

Lazard sees Amylin's exenatide as a blockbuster

Yahoo/AP

Mon, 03/2/09 - 05:44 pm